NBIO (NBIO) Stock Price & Analysis
NBIO (NBIO) rose 0.00% to USD 0 as of September 8, 2026 at 17:07 UTC, according to Nexqual real-time market data.
NBIO last closed at USD 0; the session ranged USD 0–0 on volume of 15,000 shares. Market capitalization is —, with a 52-week range of USD 0–0.13 (PNK). Source: Nexqual, September 8, 2026 at 17:07 UTC.
Key Statistics (as of September 8, 2026 at 17:07 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0.13 |
| Volume | 15,000 shares |
| Market Cap | — |
| Exchange | PNK |
Technical Analysis (NBIO)
Nexqual's technical model rates NBIO "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 17:07 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 33.33 (neutral) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SRBCF | Sirona Biochem Corp. | USD 0.01 | ▲ 0% |
| RASP | ACTAVIA LIFE SCIENCES INC | USD 0 | ▲ 0% |
| KNBIF | Kane Biotech Inc. | USD 0.02 | ▼ 9.73% |
| PKTX | ProtoKinetix, Inc. | USD 0 | ▲ 0% |
| BEGI | BlackStar Enterprise Group, Inc | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 17:07 UTC. This page is informational and not investment advice.